Marto, C.M.; Laranjo, M.; Gonçalves, A.C.; Paula, A.; Jorge, J.; Caetano-Oliveira, R.; Sousa, M.I.; Oliveiros, B.; Ramalho-Santos, J.; Sarmento-Ribeiro, A.B.;
et al. In Vitro Characterization of Reversine-Treated Gingival Fibroblasts and Their Safety Evaluation after In Vivo Transplantation. Pharmaceutics 2024, 16, 207.
https://doi.org/10.3390/pharmaceutics16020207
AMA Style
Marto CM, Laranjo M, Gonçalves AC, Paula A, Jorge J, Caetano-Oliveira R, Sousa MI, Oliveiros B, Ramalho-Santos J, Sarmento-Ribeiro AB,
et al. In Vitro Characterization of Reversine-Treated Gingival Fibroblasts and Their Safety Evaluation after In Vivo Transplantation. Pharmaceutics. 2024; 16(2):207.
https://doi.org/10.3390/pharmaceutics16020207
Chicago/Turabian Style
Marto, Carlos Miguel, Mafalda Laranjo, Ana Cristina Gonçalves, Anabela Paula, Joana Jorge, Rui Caetano-Oliveira, Maria Inês Sousa, Bárbara Oliveiros, João Ramalho-Santos, Ana Bela Sarmento-Ribeiro,
and et al. 2024. "In Vitro Characterization of Reversine-Treated Gingival Fibroblasts and Their Safety Evaluation after In Vivo Transplantation" Pharmaceutics 16, no. 2: 207.
https://doi.org/10.3390/pharmaceutics16020207
APA Style
Marto, C. M., Laranjo, M., Gonçalves, A. C., Paula, A., Jorge, J., Caetano-Oliveira, R., Sousa, M. I., Oliveiros, B., Ramalho-Santos, J., Sarmento-Ribeiro, A. B., Marques-Ferreira, M., Cabrita, A., Botelho, M. F., & Carrilho, E.
(2024). In Vitro Characterization of Reversine-Treated Gingival Fibroblasts and Their Safety Evaluation after In Vivo Transplantation. Pharmaceutics, 16(2), 207.
https://doi.org/10.3390/pharmaceutics16020207
